With an average analyst rating of hold, Bristol-Myers Squibb is clearly not a favorite. But some of the best stock picks are ...

An Avon & Somerset police officer who admitted multiple online child sex offences faces a professional misconduct hearing. PC ...

Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.

Bristol Myers Squibb (BMY) closed at $60.28 in the latest trading session, marking a +0.79% move from the prior day.

Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Children who regularly eat seafood at age 7 exhibit more positive social behaviors—such as sharing, helping, and interacting ...